OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

LILLY ELI/  US5324571083  /

SIX Swiss Exchange
9/2/2024  10:10:00 PM Chg. - Volume Bid5:31:07 PM Ask5:31:07 PM Market Capitalization Dividend Y. P/E Ratio
800.00CHF - -
Turnover: -		 -Bid Size: 0 -Ask Size: 0 780.28 bill.CHF - -
TeleTrader 8/8 Eli Lilly's Q2 revenue jumps 36% to $11.3B
GlobeNewswire 7/31 HUTCHMED Reports 2024 Interim Results and Provides Business Updates
TeleTrader 7/8 Eli Lilly launches $3.2B tender offer for Morphic
TeleTrader 7/2 US FDA approves Eli Lilly's Alzheimer's drug
TeleTrader 6/25 Lilly partners with OpenAI to combat drug-resistance bacteria
TeleTrader 6/10 FDA advisors endorse Eli Lilly's Alzheimer's drug
TeleTrader 5/24 Eli Lilly to reveal $5.3B production boost
TeleTrader 5/21 Eli Lilly's diabetes drug receives authorization in China
TeleTrader 4/30 Eli Lilly's Q1 revenue surges 26% to $8.8B
TeleTrader 3/8 Lilly's Alzheimer's drug delayed beyond Q1 2024 by FDA
GlobeNewswire 2/28 HUTCHMED Reports 2023 Full Year Results and Provides Business Updates
TeleTrader 2/26 Zealand Pharma soars 30% on positive weight-loss drug results
TeleTrader 2/6 Eli Lilly surges 5% premarket on better-than-expected results
TeleTrader 2/6 Eli Lilly revenue in Q4 up 28% to $9.35B
TeleTrader 1/4 Eli Lilly unveils website to improve weight-loss drug access
TeleTrader 10/3/2023 Eli Lilly to buy Point Biopharma for $1.4 billion
TeleTrader 8/8/2023 Eli Lilly soars 14% after upbeat earnings
TeleTrader 8/8/2023 Eli Lilly jumps 10% in premarket after earnings
TeleTrader 8/8/2023 Eli Lilly's revenue in Q2 surges 28% to $8.3B
TeleTrader 6/20/2023 Eli Lilly to acquire Dice Therapeutics for $2.4B
TeleTrader 5/3/2023 Eli Lilly soars 5% after positive Alzheimer's trial
TeleTrader 4/27/2023 Eli Lilly's Q1 net income sinks 29% to $1.35 billion
TeleTrader 4/21/2023 Drug firms CEOs to testify on insulin prices in Senate
TeleTrader 3/8/2023 Eli Lilly Alzheimer's drug fails prevention study
TeleTrader 3/1/2023 Eli Lilly caps, cuts insulin prices by 70%